Search results
FDA approves self-collection screening for virus that causes cervical cancer - The Boston Globe
The Boston Globe· 3 hours ago“It provides women who might not have otherwise had the opportunity — or inclination — to get...
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
Benzinga via Yahoo Finance· 7 hours agoTuesday, Ascendis Pharma A/S (NASDAQ:ASND) announced that the FDA extended the review date for...
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Zacks via Yahoo Finance· 10 hours agoPer the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a...
FDA greenlights self-collection of vaginal samples for cervical cancer screening
CNN via AOL· 3 hours agoInstead of a traditional speculum-involved pelvic exam to screen for cervical cancer, the US Food...
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
Zacks via Yahoo Finance· 1 day agoPhilips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power...
FDA approves HPV self-test kit
UPI· 9 hours agoEach year, about 11,500 U.S. women are diagnosed with cervical cancer and about 4,000 women die from it, according to the U.S. Centers for Disease...
FDA approves self-collection screening tests for HPV, allowing women to avoid pelvic exams for...
FierceBiotech· 10 hours agoThe FDA has approved two diagnostic devices that allow women to collect vaginal samples themselves...
FDA Recalls Insulin Pump App After 200+ Injuries
Verywell Health via Yahoo News· 11 hours agoTandem Diabetes Care Fact checked by Nick Blackmer Key Takeaways The FDA is recalling an insulin pump app. The t:connect mobile app may drain the battery...
...Keeping Track of Your Data — What You Need to Know about FDA’s Draft Guidance on Data Integrity...
The National Law Review· 5 hours agoGiven data integrity issues that have been uncovered in the past, in April 2024, the U.S. Food and...
Earnings call: Lumos Pharma gears up for Phase 3 trial of LUM-201 By Investing.com
Investing.com· 3 hours agoThe company has completed a constructive End-of-Phase 2 Meeting with the FDA and is planning to...